Consortium News

Research Symposium: Patient-Derived Xenografts

Date: May 29, 2013
Time: 9:00- 11:00 am
Location: FHCRC Arnold Building M1-A305/307

The Cancer Consortium Xenograft Resource, Breast Cancer Research Program, FHCRC Human Biology Division and UW School of Medicine are sponsoring Patient-Derived Xenografts: A Research Symposium.  The tentative agenda includes:

  • Introduction to Patient-Derived Xeongraft (PDX) resources; Byron Hann (UCSF)
  • Using PDX models for preclinical drug testing/ validation; Chris Kemp (FHCRC)
  • Clinical Trials in PDX Models; Michael Lewis (Baylor College of Medicine)
  • Local use of PDX Modesl in brain and prostate cancer; Jim Olson/ Bob Vessella (FHCRC/UW)

The Cancer Consortium Xenograft Resource; Warren Ladiges (UW.)

Space is limited.  RSVP to Marc Provence (mprov@uw.edu) by Monday, May 20.

Menu Search